MX9707150A - Uso de fumagilol y sus derivados para preparar medicamentos destinados a combatir las infecciones intestinales. - Google Patents

Uso de fumagilol y sus derivados para preparar medicamentos destinados a combatir las infecciones intestinales.

Info

Publication number
MX9707150A
MX9707150A MX9707150A MX9707150A MX9707150A MX 9707150 A MX9707150 A MX 9707150A MX 9707150 A MX9707150 A MX 9707150A MX 9707150 A MX9707150 A MX 9707150A MX 9707150 A MX9707150 A MX 9707150A
Authority
MX
Mexico
Prior art keywords
fumagillol
derivatives
intestinal infections
preparing medicaments
against intestinal
Prior art date
Application number
MX9707150A
Other languages
English (en)
Other versions
MXPA97007150A (es
Inventor
Jean-Michel Molina
Francis Derouin
Original Assignee
Sanofi Sa
Assist Publ Hopitaux De Paris
Paris
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa, Assist Publ Hopitaux De Paris, Paris filed Critical Sanofi Sa
Publication of MX9707150A publication Critical patent/MX9707150A/es
Publication of MXPA97007150A publication Critical patent/MXPA97007150A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/336—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having three-membered rings, e.g. oxirane, fumagillin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La invencion se refiere a la utilizacion del fumagilol y de los ésteres formados por el fumagilol y los ácidos (C1-C12)alquilcarboxílicos o (C1-C12)alquildicarboxílicos, saturados o insaturados, y sus sales farmacéuticamente aceptables para la preparacion de medicamentos destinados a combatir las infecciones intestinales debidas a los microsporidios y/o a los criptosporidíos.
MXPA/A/1997/007150A 1995-03-27 1997-09-19 Uso de fumagilol y sus derivados para prepararmedicamentos destinados a combatir las infecciones intestinales MXPA97007150A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9503549 1995-03-27
FR9503549 1995-03-27
FR95/03549 1995-03-27

Publications (2)

Publication Number Publication Date
MX9707150A true MX9707150A (es) 1998-07-31
MXPA97007150A MXPA97007150A (es) 1998-11-09

Family

ID=

Also Published As

Publication number Publication date
DK0817626T3 (da) 1999-07-12
EA199700267A1 (ru) 1998-04-30
JP3260378B2 (ja) 2002-02-25
SK130797A3 (en) 1998-03-04
CZ304997A3 (en) 1997-12-17
FR06C0014I2 (es) 2006-12-29
IS2048B (is) 2005-09-15
AP9701092A0 (en) 1997-10-31
AU706161B2 (en) 1999-06-10
CA2216623C (en) 2005-05-31
HUP9801220A2 (hu) 1999-09-28
SK283883B6 (sk) 2004-04-06
NO974466L (no) 1997-09-26
AP646A (en) 1998-04-27
KR100286920B1 (ko) 2001-04-16
CZ286821B6 (en) 2000-07-12
PL322470A1 (en) 1998-02-02
PL183378B1 (pl) 2002-06-28
IS4557A (is) 1997-09-11
AU5278696A (en) 1996-10-16
EP0817626A2 (fr) 1998-01-14
WO1996030010A3 (fr) 1996-11-28
KR19980703271A (ko) 1998-10-15
OA10515A (fr) 2002-04-24
EP0817626B1 (fr) 1998-10-28
UA41446C2 (uk) 2001-09-17
FR06C0014I1 (es) 2006-11-17
DE69600879D1 (de) 1998-12-03
HUP9801220A3 (en) 2001-10-29
DE69600879T2 (de) 1999-06-02
US5900431A (en) 1999-05-04
ES2128846T3 (es) 1999-05-16
JPH11506421A (ja) 1999-06-08
CA2216623A1 (en) 1996-10-03
ATE172641T1 (de) 1998-11-15
EA000150B1 (ru) 1998-10-29
CN1072485C (zh) 2001-10-10
NO974466D0 (no) 1997-09-26
TR199701048T1 (xx) 1998-01-21
HU224028B1 (hu) 2005-05-30
WO1996030010A2 (fr) 1996-10-03
CN1179715A (zh) 1998-04-22
NZ304906A (en) 1999-06-29
NO315968B1 (no) 2003-11-24

Similar Documents

Publication Publication Date Title
WO1996030010A3 (fr) Utilisation du fumagillol et ses derives pour preparer les medicaments destines a combattre les infections intestinales
NO904904L (no) Fremgangsmaate for fremstilling av en polypeptidforbindelse
GR3005035T3 (es)
EP0215654A3 (en) Macrolide antibiotics and their preparation
HUT68385A (en) Polypeptide and process for producing thereof
PT876388E (pt) Derivados de eritromicina triciclica
EP0388956A3 (en) Phthalinide derivative, pharmaceutical composition and use
DE3566404D1 (en) Substituted benzopyrans, process for their preparation and their use in medicines
IL74066A0 (en) 6,6-ethylene-15,16-methylene-3-oxo-17alpha-pregn-4-ene-21,17-carbolactones,processes for the production thereof,and pharmaceutical preparations containing them
GR3022686T3 (en) Tetrazole derivatives, process for their production and their application
IL93594A0 (en) Pharmaceutical compositions containing an imidazopyrimidone derivative
ES8502118A1 (es) Procedimiento de preparar derivados de penicilina.
AU3929789A (en) New 6-fluoro-3,5-dihydroxy carboxylic acids and derivatives thereof, a process for the preparation thereof, the use thereof as medicinal agents, pharmaceutical products and intermediates
IE893578L (en) Phenyloxypropanolamine derivatives, their preparation and¹their application in therapeutics
TW330933B (en) Furanoeremophilane and eremophilanolide sesquiterpenes for treatment of diabetes
KR920003972A (ko) 프로스타시클린 화합물을 이용한 백내장 치료
TW334437B (en) Process for the preparation of streptogramins
WO1987003590A1 (en) Medicament for the treatment of diseases of the liver
ES8704163A1 (es) Un procedimiento para preparar derivados de cefem.
DE3262231D1 (en) A novel vasodilator compound, process for the preparation thereof and pharmaceutical compositions thereform
KR910000786A (ko) 콜레스타디엔 유도체, 이의 제조방법 및 HMG-CoA 환원제를 저해하는 작용을 하는 약제로서의 이의 용도
AU7993982A (en) Tetra-peptide
NZ223022A (en) Dibenzo(be)oxepineacetic acid derivatives and pharmaceutical compositions
TW362972B (en) Use of lower alkanoyl L-carnitines to produce a medicament suitable for the therapeutic treatment of retinopathies
MX9709299A (es) Uso de las l-carnitinas de alcanoilo inferior para producir un medicamento apropiado para el tratamiento terapeutico de retinopatias.